Latest Documents


  • 27-May-2015

    English

    OECD Reviews of Health Care Quality: Portugal 2015 - Raising Standards

    This report reviews the quality of health care in Portugal, seeks to highlight best practices, and provides a series of targeted assessments and recommendations for further improvements to quality of care. The Portuguese National Health Service has responded well to financial pressure, successfully balancing the twin priorities of financial consolidation and continuous quality improvement. Even in the post-crisis years when GDP

  • 14-May-2015

    English

    The Economics of Prevention

    There is a rising concern in OECD countries about the expected growth in the burden of chronic diseases. This project is primarily focused on whether efforts should be made to prevent non-communicable diseases rather than treating and managing them.

  • 12-May-2015

    English

    Tackling Harmful Alcohol Use: Country profiles

    This data visualisation provides specific country figures and policy recommendations about alcohol consumption in OECD countries. Please use the ‘+share/embed’ button to customize this tool for your country and language and to generate an embed code for your website.

    Related Documents
  • 12-May-2015

    English

    Launch of OECD report on Tackling Harmful Alcohol Use

    The cost to society and the economy of excessive alcohol consumption around the world is massive, especially in OECD countries. This report provides clear evidence that even expensive alcohol abuse prevention policies are cost-effective in the long run and underlines the need for urgent action by governments, said OECD Secretary-General Angel Gurría, launching the report in Paris.

  • 12-May-2015

    English

    Tackling Harmful Alcohol Use - Economics and Public Health Policy

    Alcoholic beverages, and their harmful use, have been familiar fixtures in human societies since the beginning of recorded history. Worldwide, alcohol is a leading cause of ill health and premature mortality. It accounts for 1 in 17 deaths, and for a significant proportion of disabilities, especially in men. In OECD countries, alcohol consumption is about twice the world average. Its social costs are estimated in excess of 1% of

  • 12-mai-2015

    Français

    Politiques de santé

    La Division de la santé à l'OCDE analyse la performance des systèmes de santé et étudie les options politiques permettant de remédier aux problèmes de performance. Cette page liste les projets analytiques en cours.

    Also AvailableEgalement disponible(s)
  • 12-mai-2015

    Français

    L’OCDE dévoile les mesures que les gouvernements peuvent prendre pour éviter les importants surcoûts liés à une consommation nocive d’alcool

    La consommation à risque est en augmentation, chez les jeunes et chez les femmes, dans de nombreux pays de l’OCDE, en partie parce que les boissons alcoolisées sont devenues plus aisément disponibles et plus accessibles financièrement, et qu’elles font l’objet de campagnes de publicité efficaces, selon un nouveau rapport de l’OCDE.

    Documents connexes
  • 29-April-2015

    English

    Health systems are still not prepared for an ageing population

    OECD insights blog: Francesca Colombo, Head of the OECD Health Division, discusses the issues related to health systems and an ageing population.

    Related Documents
  • 15-April-2015

    English

    OECD Guide to Measuring ICTs in the Health Sector

    The OECD launched a project on “Benchmarking ICTs in health systems”, a multi-stakeholder initiative to improve the availability and quality of health ICT data through the development of a robust measurement framework and comparable cross-national measures. This task was accomplished in 2013 with the publication of an OECD “Guide to Measuring ICTs in the Health Sector”.

  • 30-March-2015

    English

    Value in Pharmaceutical Pricing

    The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.

  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 > >>